For employers, the combination of high prices and long-term use raises serious questions about sustainability
Xu J, Wei G, Wang J, Zhu J, Yu M, Zeng X, et al
Two numbers matter
Tirzepatides dual GIP/GLP-1 receptor mechanism produces greater weight loss and HbA1c reductions, as confirmed by SURMOUNT-5 and supported by the 2026 EASO pharmacotherapy update [1][10]
It is indicated for weight management for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease Zepbound comes in either a single-use pen or a single-dose vial that you would use with a needle and syringe
I'm a 9+ years HF preparer and can usually prepare a meal in significantly less time than the recipe state